Disorder | Type | Pattern of Inheritance |
Genes | Age of Onset |
Relative Frequency |
Prevale nce |
Test Availab le? |
Patent Holder (Patent Number) |
---|---|---|---|---|---|---|---|---|
Pendred's Syndrome | Syndromic | AR | SLC26A4 | Prelingual | 4–10% | SLC26A4 | ||
Type 4 Barter'st Syndrome | Syndromic | AR or digenic | BSND, CLCNKA, CLCNKB | con-sanguineous Middle Easterners | ||||
Branchio-oto-renal (BOR) Syndrome | Syndromic | AD | EYA1, SIX1 | 1 in 40,000 | EYA1, SIX1 | |||
Alport Syndrome | Syndromic | AD | MYH9, COL4A5, COL4A3, COL4A4 | Rare | MYH9, COL4A5, COL4A3, COL4A4 | |||
Fechtner's Syndrome | Syndromic | AD | MYH9 | Rare | ||||
Sebastian Syndrome | Syndromic | AD | MYH9 | Rare | ||||
(DFNA22) | Syndromic | AD | MYO6 | Postlingual | Rare | |||
Renal Tubular Acidosis | Syndromic | AR, consanguinity | ATP6B1, ATP6N1B | con-sanguineous North Africans | ||||
Waardenburg's Syndrome | Syndromic | AD or AR | PAX3, MITF, SOX10, EDN3, EDNRB | 1–4% | ||||
Wolfram Syndrome | Syndromic | AD | WFS1 | Prelingual | WFS1 | Washington University School of Medicine (WOO18787A1) | ||
Meniere's Disease | Syndromic | AD | COCH | Postlingual | COCH5B2 | Brigham and Women's Hospital (7030235), Brigham and Women's Hospital & U-Antwerp (6730475) | ||
Cockayne Syndrome Type A | Syndromic | ERCC8 | Prelingual | ERCC8 | ||||
Cockayne Syndrome Type B | Syndromic | ERCC6 | Prelingual | ERCC6 | ||||
Diabetes-Deafness Syndrome | Syndromic | MTND5, MTTL1 | MTTL1 | |||||
Charcot-Marie Tooth Neuropathy Type 1A | Syndromic | AD | PMP22 | PMP22 | ||||
Charcot-Marie Tooth Neuropathy Type 1B | Syndromic | AD | MPZ | MPZ | ||||
Charcot-Marie Tooth Neuropathy Type 1C | Syndromic | AD | LITAF | LITAF | ||||
Charcot-Marie Tooth Neuropathy Type 1D | Syndromic | AD | EGR2 | EGR2 | ||||
Charcot-Marie Tooth Neuropathy Type 1E | Syndromic | AD | PMP22 | PMP22 | Athena (5691144), Athena (6001576) | |||
Charcot-Marie Tooth Neuropathy Type 1F/2E | Syndromic | AD | NEFL | NEFL | ||||
Isolated Renal Hypomagnesemia | Syndromic | CLDN16, | CLDN16, | |||||
Urticaria-Deafness-Amyloidosis (UDA) Syndrome | Syndromic | CIAS1, NLRP3 | CIAS1, NLRP3 | |||||
Long QT Syndromes and Deafness | Syndromic | KVLQT1, SCN5A | KVLQT1, SCN5A | U-Utah Research Foundation (20020061524A1), U-Utah Research Foundation and Genzyme, Inc (6582913), U-Utah Research Foundation (6787309) | ||||
Jervell and Lange Nielsen (JLN) Syndrome | Syndromic | AR | KLVQT1, KCNQ1 (JLN1), KCNE1 (JLN2) | Prelingual | Rare | KLVQT1, KCNQ1 (JLN1), KCNE1 (JLN2) | U-Utah Research Foundation (6150104) | |
Stickler Syndrome | Syndromic | AD | COL11A2, COL2A1, COL11A1, COL9A1 | COL11A1, COL11A2, COL2A1, COL9A1 | ||||
Epstein Syndrome | Syndromic | AD | MYH9 | MYH9 | ||||
Norrie Disease | Syndromic | NDP | NDP | |||||
Treacher Collins Syndrome | Syndromic | TCOF1 | TCOF1 | |||||
Usher Syndrome Type I (USH1) | Syndromic | AR | MY07A,O USH1C, CDH23, PCDH15, SANS | Prelingual | all Usher combined 3–6% of child deafness | all Usher combined 4.4/100,000 | MY07A, PCDH15 | |
Usher Syndrome Type II (USH2) | Syndromic | AR | USH2A, VLGR1, WHRN | Prelingual | all Usher combined 3–6% of child deafness | all Usher combined 4.4/100,001 | USH2A | |
Usher Syndrome Type III (USH3) | Syndromic | AR | USH3 | Postlingual | all Usher combined 3–6% of child deafness | all Usher combined 4.4/100,002 | USH3A (CLRN1) | |
Kearns-Sayre Syndrome | Syndromic | Mitochondrial | mtDNA deletion syndromes | |||||
Pearson Syndrome | Syndromic | Mitochondrial | mtDNA deletion syndromes | |||||
Progressive External Ophthalmoplegia | Syndromic | Mitochondrial | mtDNA deletion syndromes | |||||
Leigh Syndrome | Syndromic | Mitochondrial | MTATP6, MTTL1, MTTK, MTND1, MTND3, MTND4, MTND5, MTND6, MTCO3, MTTW, and MTTV | MT-ATP6, MT-CO3, MT-ND1, MT-ND3, MT-ND4, MT-ND5, MT-ND6, MT-TK, MT-TL1, MT-TV, MT-TW | ||||
NARP | Syndromic | Mitochondrial | MTATP6 | MT-ATP6 | ||||
MELAS | Syndromic | Mitochondrial | MTTL1, MTND5, MT-TC, MT-TV, MT-TF, and MT-TS1 | MTTL1, MTND5 | ||||
MERRF | Syndromic | Mitochondrial | MTTK | MTTK | ||||
Vohwinkel Syndrome | Syndromic | GJB2 (Cx 26) | GJB2 >50% | GJB2 (Cx 26) | Institut Pasteur (5998147, 6485908) | |||
Deafness-Dystonia Syndrome (DDON) | Syndromic | XL | TIMM8A | Varies | ||||
Hypoparathyroidism, Sensorineural Deafness, and Renal (HDR) Disease | Syndromic | GATA3 | GATA3 | |||||
Ichthyosis, Hystrix-like, with Deafness | Syndromic | GJB2 (Cx 26) | GJB2 (Cx 26) | Institut Pasteur (5998147, 6485908) |